We’re proud to announce that this year the BSI’s official journals have achieved their highest impact factors so far: Immunology has reached an IF of 4.147 and Clinical & Experimental Immunology has reached 3.711.
We’d like to take this opportunity to celebrate our journals for building upon their position as highly respected publications within the field of immunology. We’d like to thank our editorial teams, led by Editors-in-Chief Leonie Taams and Simon Milling, for their ongoing commitment to the journals, and everyone who has contributed to the continued success of our journals, including authors, readers, reviewers and editors.
Here you can find information about Immunology and Clinical & Experimental Immunology. Profits derived from the sale of the journals are invested back into the BSI to benefit our members in the form of grants, travel awards, regional and affinity group meetings, our popular annual Congress and other key initiatives. We encourage you to support the BSI by submitting your work.